4//SEC Filing
Lewis-Hall Freda C 4
Accession 0001641172-25-002240
CIK 0001896212other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 9:13 PM ET
Size
7.3 KB
Accession
0001641172-25-002240
Insider Transaction Report
Form 4
Lewis-Hall Freda C
Director
Transactions
- Award
Common Stock
2025-03-30$0.89/sh+47,612$42,375→ 51,991 total
Holdings
- 20,033(indirect: See Footnote)
Common Stock
- 5,169(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents shares issued pursuant to the 2023 Stock Incentive Plan, in lieu of $42,375 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program.
- [F2]The shares are held of record by Intelmed LLC ("Intelmed"). Ms. Lewis-Hall is the Managing Director of Intelmed and in such capacity has voting and investment discretion with respect to the Shares held of record by Intelmed. By virtue of this relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of the shares held of record by Intelmed. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.
- [F3]The shares are held by Ms. Lewis-Hall's spouse, Mr. Emerson Hall, Jr. As Mr. Hall's spouse and by virtue of their relationship, Ms. Lewis-Hall may be deemed to share beneficial ownership of such shares held by record by Mr. Emerson Hall, Jr. Ms. Lewis-Hall disclaims any such beneficial ownership except to the extent of her pecuniary interest therein.
Documents
Issuer
CONDUIT PHARMACEUTICALS INC.
CIK 0001896212
Entity typeother
Related Parties
1- filerCIK 0001437909
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 9:13 PM ET
- Size
- 7.3 KB